Calidi Biotherapeutics In...

AMEX: CLDI · Real-Time Price · USD
5.28
0.24 (4.76%)
At close: Aug 15, 2025, 3:59 PM
5.24
-0.76%
After-hours: Aug 15, 2025, 07:55 PM EDT

Calidi Biotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021
Period Ending Jun 30, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021
Net Income
-21.75M -16.75M -11.1M -8.59M -156.54K 3.53M 10.41M 9.09M 4.93M 3.47M -823.29K
Depreciation & Amortization
1.2M 1.01M 738K 706K 342K 159K 68K n/a n/a n/a n/a
Stock-Based Compensation
4.26M 4.81M 4.68M 4.63M 3.55M 2.12M 1.06M n/a n/a n/a n/a
Other Working Capital
-984.12K -72K -6.69M 6.44M 5.07M 3.28M 1.78M -162.53K -255.48K -319.2K -1.36M
Other Non-Cash Items
-3.2M -3.53M -2.73M 3.56M -4.15M -6.69M -12.81M -10.69M -6.17M -4.18M 718.08K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-6.19M -6.24M -6.7M 6.43M 5.06M 3.26M 1.84M -98.7K -191.64K -255.37K -1.36M
Operating Cash Flow
-31.01M -26.98M -20.63M 1.41M 755.47K 98.05K -561.64K -1.7M -1.43M -964.09K -1.47M
Capital Expenditures
-896K -1.03M -1.12M -671K -365K -228K -67K n/a n/a n/a n/a
Cash Acquisitions
9K 9K 9K n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
425.85K n/a -2.32M -3.67M -2.75M -2.32M n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a 190.01M 190.63M 190.01M 190.01M n/a n/a n/a n/a n/a
Other Investing Acitivies
170K 170K -189.46M 63K n/a n/a 189.59M n/a n/a n/a n/a
Investing Cash Flow
-57.15K -478K -2.35M 186.97M 187.26M 187.69M 189.59M -230M -230M -230M -230M
Debt Repayment
2.36M -597K 2.5M 1.51M 1.01M 789.5K -943K -1.12M -1.12M -1.12M -188.8K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-4.39M -4.23M -47K 10.06M 6.77M 7.5M 6.41M 3.6M 823.94K 91.94K -2.34M
Financial Cash Flow
31.83M 29.04M 32.8M -188.03M -188.53M -188.75M -190.19M 231.93M 231.93M 231.93M 232.57M
Net Cash Flow
1.16M 1.96M 10.21M 341.02K -514.69K -968.76K -1.16M 233.84K 502.52K 967.65K 1.1M
Free Cash Flow
-31.9M -28.01M -21.75M 734.64K 390.47K -129.95K -628.64K -1.7M -1.43M -964.09K -1.47M